Advances in targeting SRC in the treatment of breast cancer and other solid malignancies

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Erica L Mayer, Ian E Krop

Abstract

Src, a membrane-associated nonreceptor tyrosine kinase, plays a crucial role in the coordination and facilitation of cell-signaling pathways controlling a wide range of cellular functions, including growth, survival, invasion, adhesion, and migration. Deregulation and increased activity of Src has been observed in multiple human malignancies, prompting the development of specific inhibitors of Src. In preclinical studies, Src inhibitors show antitumor effects in multiple solid tumor types. Recently completed early-phase trials using the inhibitors dasatinib and bosutinib have suggested modest activity as monotherapy in breast and prostate cancer, with potentially greater activity in combination regimens. Given the interaction between Src and the estrogen receptor, ongoing trials are exploring combinations with endocrine therapy. The relationship between Src and the vascular endothelial growth factor receptor also justifies investigation of combinations with angiogenesis inhibitors. Future trials will continue to explore the contribution of Src inhibition with both chemotherapy and targeted agents.

References

Oct 1, 1992·The Journal of Clinical Investigation·B F BoyceG R Mundy
Jan 1, 1994·Molecular and Cellular Biology·S K MuthuswamyW J Muller
Jan 1, 1997·Annual Review of Cell and Developmental Biology·S M Thomas, J S Brugge
Dec 15, 2000·Oncogene·R B Irby, T J Yeatman
Jul 30, 2003·Cancer Metastasis Reviews·Justin M Summy, Gary E Gallick
Jan 24, 2004·The Journal of Biological Chemistry·Tsuyoshi MiyazakiRoland Baron
Oct 19, 2004·Oncogene·Sarah J Parsons, J Thomas Parsons
Jun 17, 2005·Cancer Research·Jennifer M GolasFrank Boschelli
Aug 16, 2005·Current Opinion in Cell Biology·Egle Avizienyte, Margaret C Frame
Dec 8, 2005·Breast Cancer Research and Treatment·Stephen HiscoxRobert I Nicholson
Jun 16, 2006·The New England Journal of Medicine·Moshe TalpazCharles L Sawyers
Aug 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew Berchuck
Aug 28, 2007·Nature Biotechnology·Marcus BantscheffGerard Drewes
Dec 7, 2007·Cancer Biology & Therapy·Neelima DenduluriSandra M Swain
May 22, 2008·Breast Cancer Research and Treatment·S HiscoxR I Nicholson
Mar 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Prateek MendirattaPhillip G Febbo
Apr 29, 2009·Cancer Letters·Jyoti NautiyalAdhip P N Majumdar
May 19, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Oleg TatarovJoanne Edwards
May 20, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yi ChenJoyce M Slingerland
May 20, 2009·The Journal of Clinical Investigation·Martin L SosRoman K Thomas
Oct 1, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·George D DemetriT R Jeffry Evans

❮ Previous
Next ❯

Citations

Aug 21, 2013·Cell Biology and Toxicology·Rocio Castillo-SanchezEduardo Perez Salazar
Dec 2, 2011·Clinical & Experimental Metastasis·Lori RiceDietmar W Siemann
Jan 17, 2013·Current Treatment Options in Oncology·J M Clarke, A J Armstrong
Apr 9, 2011·Nature Medicine·Senthil K Muthuswamy
Mar 6, 2013·Nature Reviews. Clinical Oncology·Dimitrios ZardavasMartine Piccart
Jun 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Richard MarcotteWilliam J Muller
Mar 17, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M N FornierC A Hudis
Jul 14, 2012·Carcinogenesis·Anatoliy SamoylenkoLyudmyla Drobot
Oct 23, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Seth A WanderJoyce M Slingerland
Jan 25, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Won Gu KimSheue-yann Cheng
Aug 16, 2012·Genes & Cancer·Mathilde GlénissonIvan Bièche
Sep 26, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Justin N Bottsford-MillerAnil K Sood
Jul 5, 2013·PloS One·François FerriereGilles Flouriot
Jun 13, 2013·Biochimica Et Biophysica Acta·Caroline E Nunes-XavierRafael Pulido
Oct 16, 2012·EMBO Molecular Medicine·Coralie PoulardMuriel Le Romancer
Sep 15, 2011·Expert Opinion on Pharmacotherapy·Philippe A CassierJean-Yves Blay
Mar 14, 2013·Expert Opinion on Medical Diagnostics·Marisa P Dolled-Filhart, Mark D Gustavson
May 16, 2015·Molecular Medicine Reports·Juan XiaoJundong Li
Jun 19, 2013·Critical Reviews in Oncology/hematology·Girolamo RanieriRaffaele Luigi Sciorsci
Apr 12, 2012·Drug Discovery Today·Neil O CarragherMargaret C Frame
Dec 14, 2011·Trends in Pharmacological Sciences·Siyuan Zhang, Dihua Yu
May 27, 2011·Seminars in Oncology·Harold J Burstein
Jul 22, 2011·Journal of Signal Transduction·Banibrata Sen, Faye M Johnson
Jul 23, 2015·Applied Immunohistochemistry & Molecular Morphology : AIMM·Rong LiShi Wei
Aug 17, 2014·Experimental Cell Research·Simona Delle MonacheAdriano Angelucci
May 15, 2012·International Journal of Cancer. Journal International Du Cancer·Michael J DuffyJohn Crown
Jul 26, 2011·Cancer Science·Shunji TakahashiKiyohiko Hatake
Oct 26, 2012·Pigment Cell & Melanoma Research·Jose L Orgaz, Victoria Sanz-Moreno
Apr 26, 2013·The Journal of Pathology·Saadia A KarimValerie G Brunton
Nov 9, 2011·The FEBS Journal·Bradley R GrovemanXianMin Yu
Aug 20, 2014·BioMed Research International·Laura ContiStefania Lanzardo
May 10, 2012·Cellular Signalling·María Pilar Sánchez-BailónJorge Martín-Pérez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

Nature Reviews. Clinical Oncology
Lori C KimEric B Haura
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Yi ChenJoyce M Slingerland
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Erica L MayerAntonio Llombart-Cussac
© 2021 Meta ULC. All rights reserved